Advisors Preferred’s Pediatrix Medical MD Stock Holding History

Advisors Preferred’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-235,435	Closed	-$1.67M	–	228
2024 Q2	$1.67M	Buy	+235,435	New	+$1.95M	0.29%	62
2023 Q3	–	Sell	-158,407	Closed	-$2.21M	–	237
2023 Q2	$2.21M	Buy	+158,407	New	+$2.22M	0.54%	38
2023 Q1	–	Sell	-139,225	Closed	-$2.09M	–	240
2022 Q4	$2.09M	Buy	+139,225	New	+$2.27M	0.89%	23

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Advisors Preferred's MD Position: Q3 2024 in Review

Advisors Preferred sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 235,435 shares — an estimated $1.67M sold.

Advisors Preferred first reported a position in MD in Q4 2022 and held it in 3 quarters. The position peaked at $2.21M in Q2 2023. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

Advisors Preferred reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
Advisors Preferred sold 235,435 Pediatrix Medical shares in Q3 2024, an estimated $1.67M.
Advisors Preferred first reported a position in Pediatrix Medical in Q4 2022 and held it in 3 quarters.
Advisors Preferred's Pediatrix Medical position peaked at $2.21M in Q2 2023.
218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on Advisors Preferred's 13F filing for Q3 2024, filed 15 Oct 2024.